ArticleFrontiers in pharmacology2025

Entrectinib can induce nerve cell damage by inhibiting PI3K-AKT and TGF-β signaling pathways.

Qingshan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.